ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2016
An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders.
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Factors influencing family physicians' willingness to prescribe opioid agonist therapy using virtual modalities: a qualitative analysis.Frontiers in medicine · 2026Article
- "We need all hands on deck": characterizing addiction medicine training in Canada-a mixed methods study of fellowship program directors.Addiction science & clinical practice · 2025Article
- Reframing conceptualizations of primary care involvement in opioid use disorder treatment.BMC primary care · 2024Article
- Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.Substance abuse treatment, prevention, and policy · 2022Review
- Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.Harm reduction journal · 2020Article
- A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.Substance abuse treatment, prevention, and policy · 2020Article
- Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.American journal of public health · 2020Article
- Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis.PLoS medicine · 2019Article
- Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.Spatial and spatio-temporal epidemiology · 2019Article
- High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.Addiction (Abingdon, England) · 2018Article
- Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.Drug and alcohol dependence · 2018Article
- The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.Contemporary clinical trials · 2018Article
- The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
- Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.